Hosted on MSN

Expediting parallel drug approval pathways is challenging, but rewarding

Global agencies have collaborated to create parallel regulatory approval solutions to help get drugs to patients more quickly. Experts who have used these schemes say that while these schemes have ...

FDA proposes new treatment approval pathway for ultra-rare diseases

The Food and Drug Administration (FDA) on Monday announced a new proposal for flexible drug approval pathway treatments ...
Forbes

FDA’s Conditional Approval Plan Would Unleash Biotech Innovation

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. In a move that could dramatically reshape the landscape for rare ...
JD Supra

FDA’s Recent Guidance on Accelerated Approval and Implications for Rare Diseases

- In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed and Health Law Scan, focusing on issues impacting the rare disease ...
News Medical

The benefits and challenges of FDA Fast-Track and Accelerated Approval in drug development

The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions. The FDA Fast ...
JD Supra

FDA Announces “plausible Mechanism” Approval Pathway for Certain Personalized Therapies, With Few Details

Late on Wednesday, U.S. Food and Drug Administration (FDA) Commissioner Marty Makary and Center for Biologics Evaluation & Research (CBER) Director Vinay Prasad published an article in the New England ...